Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group

詳細情報 詳細情報について

• CRID

  1360567182301620096

• DOI

  10.1016/j.leukres.2017.01.003

• ISSN

  01452126

• Web Site

  https://api.elsevier.com/content/article/PII:S0145212617300036?httpAccept=text/plain

  https://api.elsevier.com/content/article/PII:S0145212617300036?httpAccept=text/xml

• データソース種別

  • Crossref
  • KAKEN